Press release
Gene Therapy Market Grows at 22.8% CAGR to 2035
The Gene Therapy Market is at the forefront of revolutionizing modern medicine, offering the promise of treating and in some cases curing, previously untreatable genetic disorders. Gene therapy uses DNA or RNA-based vectors to correct or replace defective genes, targeting the root cause of diseases rather than managing symptoms. This approach is transforming patient care in areas like oncology, rare diseases, neurological disorders, and ocular conditions, opening the door to highly personalized and precision medicine solutions.
In 2025, the global gene therapy market attained a valuation of USD 9.59 billion. With the rapid pace of technological advancements, increasing research funding, and rising clinical adoption, the market is projected to grow at an impressive CAGR of 22.80% between 2026 and 2035, reaching USD 74.78 billion by 2035.
Get a Free Sample Report with Table of Contents - https://www.expertmarketresearch.com/reports/gene-therapy-market/requestsample.
Gene Therapy Market Overview
Gene therapy involves introducing, removing, or modifying genetic material within a patient's cells to treat disease. Therapeutic approaches include:
Viral vectors (adenoviral, retroviral, adeno-associated viral vectors)
Non-viral vectors (plasmids, oligonucleotides)
Genome-editing techniques such as CRISPR-Cas9
The market is fueled by growing clinical approvals, breakthrough therapies, and increased focus on personalized treatment strategies. Gene therapy addresses conditions with high unmet medical needs, including rare genetic disorders, cancers, and degenerative diseases.
Key Growth Drivers of the Gene Therapy Market
Rising Incidence of Genetic and Rare Diseases
The prevalence of genetic disorders, neurological conditions, and rare diseases has increased awareness and demand for curative therapies. Conditions such as spinal muscular atrophy (SMA), hemophilia, and inherited retinal disorders are driving adoption of gene therapy solutions.
Technological Advancements
Innovations in gene editing, viral vector development, and delivery systems have enhanced the safety and efficacy of gene therapies. These include:
Improved viral vector designs with higher specificity
CRISPR-Cas9 and base-editing platforms for precise gene modification
Nanoparticle-based non-viral delivery systems
Increased Investment and Funding
Venture capital, government grants, and strategic partnerships in gene therapy research are accelerating clinical development. Significant funding is aimed at addressing high unmet medical needs and enabling faster commercialization.
Regulatory Support
Regulatory agencies in the US, EU, and Asia-Pacific have introduced expedited pathways for gene therapy approvals, such as Breakthrough Therapy Designation and Orphan Drug Designation, reducing development timelines and costs.
Growing Adoption of Personalized Medicine
As healthcare moves toward precision medicine, gene therapies are increasingly preferred for patients with specific genetic profiles, offering tailored and potentially curative treatments.
Emerging Trends in the Gene Therapy Market
Expansion in Oncology Applications
Gene therapy in oncology is expanding rapidly, with CAR-T cell therapies and gene-engineered immune cells providing innovative treatment options for hematologic malignancies and solid tumors.
Shift Toward Rare Disease Therapies
The market is increasingly focusing on rare genetic disorders, as these indications often benefit from expedited regulatory pathways and high reimbursement potential.
Combination Therapies
Gene therapies are being explored in combination with conventional chemotherapy, immunotherapy, or targeted therapy to enhance treatment outcomes.
Global Clinical Trials and Collaborations
Collaborations between biopharma companies and academic research institutes are facilitating global clinical trials, reducing costs, and accelerating therapy development.
Gene Therapy Market Segmentation Analysis
By Indication
Neurological Disorders
Includes treatments for conditions such as spinal muscular atrophy (SMA), Huntington's disease, and Parkinson's disease.
Rising prevalence of neurological genetic disorders is fueling growth in this segment.
Oncological Disorders
CAR-T therapies, gene-engineered T cells, and oncolytic viruses are driving the oncology segment.
Rare Diseases
High unmet medical needs and regulatory incentives are boosting development for rare genetic disorders.
Eye Disorders
Gene therapies targeting inherited retinal diseases, such as Leber congenital amaurosis, are emerging as key growth drivers.
Others
Cardiovascular, metabolic, and immune-related gene therapy applications are also expanding.
Read the Full Report with the Table of Contents - https://www.expertmarketresearch.com/reports/gene-therapy-market.
By Vector
Viral Vectors
Retroviral Vectors: Widely used in ex vivo gene therapy for hematopoietic stem cells.
Adeno-associated Viral Vectors (AAVs): Popular due to their safety, low immunogenicity, and long-term gene expression.
Other Viral Vectors: Include adenoviruses and lentiviruses with varied clinical applications.
Non-Viral Vectors
Oligonucleotides: Include antisense oligonucleotides (ASOs) and siRNA therapies.
Others: Plasmid DNA and nanoparticle-based delivery systems offer alternatives to viral vectors, with reduced immunogenicity.
By Region
North America
North America dominates the gene therapy market, driven by strong research infrastructure, advanced healthcare systems, and supportive regulatory frameworks. The United States leads clinical development and commercial adoption.
Europe
Europe represents a significant share of the market, supported by:
Government-backed gene therapy research
Strong pharmaceutical presence
Collaborative networks across countries like Germany, UK, France, and Italy
Asia Pacific
The Asia Pacific market is expanding rapidly due to increasing R&D investments, regulatory harmonization, and growing awareness of genetic disorders. Key markets include China, Japan, India, and Australia.
Latin America
Steady growth in Latin America is supported by improving clinical research infrastructure and government initiatives to adopt advanced therapies.
Middle East and Africa
Although nascent, this region shows potential with expanding healthcare infrastructure, particularly in Saudi Arabia, UAE, and South Africa.
By Key Players
The gene therapy market is highly competitive, with leading pharmaceutical and biotechnology companies focusing on R&D, strategic partnerships, and acquisitions.
Companies Covered:
AstraZeneca
Boehringer Ingelheim
GlaxoSmithKline plc
Novartis AG
CHIESI Farmaceutici SpA
Sunovion Pharmaceuticals
Teva Pharmaceutical Industries Ltd
Mylan N.V., Orion Corporation
Merck & Co., Inc.
Grifols, S.A.
Abbott
F. Hoffmann-La Roche Ltd
Vectura Group plc
Pfizer Inc, Alkermes
Biogen
Astellas Pharma Inc
Key Competitive Strategies:
Licensing and acquisition of innovative gene therapy technologies
Collaboration with academic institutions for pipeline expansion
Geographic expansion into high-growth emerging markets
Challenges in the Gene Therapy Market
Despite the strong growth trajectory, the market faces several challenges:
High Cost of Therapy: Gene therapies are expensive, limiting patient access and adoption.
Manufacturing Complexities: Scaling production of viral and non-viral vectors is technically demanding.
Regulatory Hurdles: Despite expedited pathways, regulatory approvals are complex due to safety and long-term efficacy requirements.
Safety and Immunogenicity: Adverse immune responses and off-target effects remain key concerns.
Addressing these challenges is crucial for broader market adoption and patient accessibility.
Future Outlook of the Gene Therapy Market
The Gene Therapy Market is poised for rapid expansion, driven by:
Increasing R&D investment in rare and genetic disorders
Technological advancements in viral vectors and gene-editing tools
Adoption of personalized medicine and precision therapeutics
By 2035, the market is expected to reach USD 74.78 billion, establishing gene therapy as a cornerstone of next-generation medicine. Innovations in delivery systems, regulatory support, and global collaborations will continue to accelerate growth.
See More Reports
Emergency Escape Breathing Device Market - https://bit.ly/3X6PmdR.
Nootropics Market - https://bit.ly/4oNrHvd.
Peripheral Neuropathy Treatment Market - https://www.linkedin.com/pulse/peripheral-neuropathy-treatment-market-growth-outlook-roshan-kumar-zo1qc.
Oxygen Therapy Market - https://www.linkedin.com/pulse/oxygen-therapy-market-outlook-industry-analysis-2035-roshan-kumar-hgytc.
Media Contact
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gene Therapy Market Grows at 22.8% CAGR to 2035 here
News-ID: 4334041 • Views: …
More Releases from Expert Market Research
Epigenetics Market to Reach USD 5.33B by 2035
How Is the Epigenetics Market Transforming the Future of Precision Medicine and Disease Research?
The Epigenetics Market has emerged as one of the most dynamic and transformative segments of the global life sciences industry. By focusing on heritable changes in gene expression that do not alter the DNA sequence, epigenetics is reshaping how researchers and clinicians understand disease mechanisms, drug responses, and personalized medicine. From cancer research to developmental biology and…
3D Neuroscience Market Expands at 15.2% CAGR
How Is the 3D Neuroscience Market Revolutionizing Brain Research and Clinical Decision-Making?
The 3D Neuroscience Market is redefining how scientists, clinicians, and healthcare systems understand the human brain. By enabling high-resolution, three-dimensional visualization and functional mapping of neural structures, 3D neuroscience technologies are unlocking deeper insights into neurological disorders, cognitive function, and brain connectivity. As brain-related diseases rise globally and precision medicine gains momentum, 3D neuroscience has moved from a niche…
Global Fertility Test Market to Hit USD 1.31B by 2035
Can the Fertility Test Market Redefine Early Family Planning in a World Facing Rising Infertility?
The Fertility Test Market has emerged as a critical segment of the global reproductive health ecosystem, addressing one of the most pressing healthcare and social challenges of our time-infertility. As more individuals and couples seek early insights into their reproductive health, fertility testing solutions are becoming an essential first step in family planning, clinical decision-making, and…
Non-Hodgkin's Lymphoma Treatment Market to Hit USD 28.88B
How Is the Non-Hodgkin's Lymphoma Treatment Market Evolving with Advances in Precision Oncology?
The Non-Hodgkin's Lymphoma Treatment Market is undergoing a significant transformation as advances in immunotherapy, targeted therapy, and diagnostic technologies redefine how this complex group of blood cancers is treated. Non-Hodgkin's lymphoma (NHL) includes a diverse range of lymphatic system malignancies, varying widely in aggressiveness, genetic profile, and response to therapy. As a result, treatment strategies are becoming increasingly…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
